top of page
Dr. Phillippe Robaey

University of Ottawa, Ontario, Canada

Dr. Robaey is a psychiatrist with a specialty in child and adolescence psychiatry. He is presently full professor in the department of psychiatry of the faculty of medicine (University of Ottawa), associate professor in the School of Psychology (University of Ottawa) and in the department of psychiatry (Université de Montréal), and research adjunct professor in the department of neuroscience of Carleton University. He is an internationally recognized expert in Attention Deficit Hyperactivity Disorder (ADHD) and head of the specialized clinic for ADHD and disruptive behavior at CHEO. He is also a specialist in mental health outcome of children treated for chronic diseases (leukemia, prematurity, genetic disorders like tyrosinemia, etc.). More recently he started working on services of mental health services in primary care and empowering families in treatment, and in global mental health in China.

After an MD at the Free University at Brussels and a specialty in neuropsychiatry at the Catholic University of Leuven, he obtained a PhD in Health Sciences (psychophysiology) at the Université Paris 6. After postdoctoral studies at the Cognitive Psychophysiology, Psychiatry and Neurology Research Unit, National Center for Scientific Research (CNRS) in the Pitié-Salpêtrière Hospital (Paris). Dr. Robaey then continued his research at the Sainte- Justine University Hospital Center (Montreal) where he became Chercheur National du Fonds de Recherche en Santé du Québec, then at the Children Hospital of Eastern Ontario (CHEO) and the Ottawa University Institute of Mental Health Research (Ottawa).

In addition to his salary support, Dr. Robaey has been awarded over 10 M$ in peer-reviewed research grant, 1 M$ in non-peer-reviewed research grants and about 17M$ through large research network. Dr. Robaey is author of over 110 papers and has delivered about 90 national and 230 international lectures. He participated in the creation of an option in psychiatric sciences (master and PhD level) in the program of biomedical sciences at the faculty of medicine (Université de Montréal), supervised about 60 students, and teaches innovative courses in psychiatry. He is a member of the Canadian Academy of Child and Adolescent Psychiatry and on the editorial journal of this association. He is a regular reviewer in many peer-reviewed journals and granting agencies (e.g., CIHR).

His current work in the creation of computational model to better understand ADHD and its pharmacological treatment, developing precision medicine approach to treat ADHD and the use of home-based visuoconference in child and youth mental health care.

bottom of page